Monday, October 26, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Vanta Holdings Inc. (CN:VNTA) Gains 3.75% as Peptide Therapy Expansion, Fresh Financing and Longevity Market Opportunities Lift Investor Optimism

TR
By Tom Reyes · Markets Editor
Oct 22 07:40 ETSource: kalkine.ca

From the source

Vanta Holdings Inc. (CN:VNTA) Gains 3.75% as Peptide Therapy Expansion, Fresh Financing and Longevity Market Opportunities Lift Investor Optimism

Read at kalkine.ca
PeptiPrescribed peptides from $99/moSee all →